IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Sotac Pharmaceuticals IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Beeline Capital Advisors Private is the merchant banker of Sotac Pharmaceuticals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 7th February 2023.
Sotac Pharmaceuticals IPO open date is 29th March 2023 and close date is 3rd April 2023. IPO Allotment Date is 10th April 2023 and Listing date is 13th April 2023.Sotac Pharmaceuticals IPO size is Rs 33.30 Cr. crores with IPO price of Rs 111.00 Cr.. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Beeline Capital Advisors Private Limited is the book-running lead manager of the Sotac Pharmaceuticals IPO. Kfin Technologies Limited is the Registrar and Market Maker is Sunflower Broking Private Limited for Sotac Pharmaceuticals IPO.
Sotac Pharmaceuticals IPO anchor investors are the below investors. The number of anchor investors in this IPO is 3.
| Anchor Investor Name | No. of shares Allotted | Offer Price (in Rs.) | Amount Invested (in Rs.) |
|---|---|---|---|
| Nav Capital Vcc | 490,800.00 | ₹111.00 | ₹54,478,800.00 |
| Ag Dynamic Fund | 181,200.00 | ₹111.00 | ₹20,113,200.00 |
| Forbes Emf | 181,200.00 | ₹111.00 | ₹20,113,200.00 |
Sotac Pharmaceuticals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Sotac Pharmaceuticals IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on Manufacturing of pharmaceutical products. The company is launching its SME IPO on the NSE EMERGE exchange, using the Book Building Issue method. Sotac Pharmaceuticals IPO size is ₹ 33.30 Cr. Crores with fresh issue size of Rs 33.30 Cr. Crores and Offer for sale being Nil.
The IPO allotment date for Sotac Pharmaceuticals IPO is expected to be 10th April 2023, after the finalization of basis of allotment. Investors can check Sotac Pharmaceuticals IPO allotment status on the registrars website, Kfin Technologies Limited. Sotac Pharmaceuticals IPO refund dates are 11th April 2023.
Sotac Pharmaceuticals IPO is expected to be listed on 13th April 2023.
The upper price band for the Sotac Pharmaceuticals IPO is set at ₹ 111.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Sotac Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Sotac Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 3rd April 2023. After submission, funds are blocked until the basis of allotment of Sotac Pharmaceuticals IPO is finalised.
The merchant banker for Sotac Pharmaceuticals IPO is Beeline Capital Advisors Private Limited . Beeline Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Sotac Pharmaceuticals IPO RHP for further details.
The registrar for Sotac Pharmaceuticals IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Sotac Pharmaceuticals IPO through their official website or helpline.
Sotac Pharmaceuticals IPO was subscribed 1.60 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 33.30 Cr.
Avg IPO Size (Sector Based)
:
₹ 23.81 Cr.
Sector: Pharmaceutical
SME IPO so far:
34
Merchant Banker:
Beeline Capital
SME IPO by BRLM so far:
47
City:
Ahmedabad
SME IPO so far:
174
Revenue (annualised):
₹ 79.48 cr.
PE
Ratio:
132.14x
Average Sector PE Ratio: 20.29x
Sotac Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Sotac Pharmaceuticals Financial Review Page
Merchant Banker(s) of Sotac Pharmaceuticals IPO: Beeline Capital Advisors Private Limited
Sotac Pharmaceuticals IPO subscription was 1.60 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sotac Pharmaceuticals IPO listed at a listing price of 115.00 against the offer price of 111.00.
The current market price of Sotac Pharmaceuticals is 118.70.
Why Us?
